Barclays »

Newamsterdam Pharma Co Nv shares owned by Barclays

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.0k 513 11.70
2023-09-30 $5.0k 513 9.75

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Viking Global Investors
RA Capital Management
Medicxi Ventures Management
BVF
Goldman Sachs Group
GMT Capital Corp
Millennium Management
Alyeska Investment Group
Opaleye Management
Schonfeld Strategic Advisors
Marshall Wace
Yarbrough Capital
HealthInvest Partners AB

View all funds holding Newamsterdam Pharma Co Nv